Colorado BioScience Association, Senator Michael Bennet Host U.S. Food and Drug Administration Commissioner, Dr. Scott Gottlieb, for Life Science Industry Roundtable

Colorado life science leaders cover the regulatory landscape for diagnostics, FDA's approach to bioscience and technology and the 21st Century Cures Act – progress and future outlook

Colorado BioScience Association (CBSA) and Senator Michael Bennet introduced the new U.S. FDA Commissioner, Dr. Scott Gottlieb, to Colorado's inventive life science sector today. CBSA and Senator Bennet co-hosted a roundtable discussion at the University of Colorado Anschutz Medical Campus covering topics including clinical trials, Breakthrough Therapy Designation, precision and regenerative medicine, the regulatory landscape for diagnostics, the digital health regulatory action plan, and the implementation of the 21^st Century Cures and MEDTECH acts with the Commissioner, who was appointed in May.

More than 60 of the state's life science innovators, including CEOs, academic leaders and researchers shared their views on progress and the future outlook for the industry in Colorado at this morning's roundtable discussion, held at University of Colorado Anschutz Medical Campus in Aurora.

April Giles, President and CEO of CBSA says:
"It's an honor for CBSA to co-host Dr. Gottlieb with Senator Bennet and introduce him to the dynamic industry leaders in our state. His visit to Colorado highlights our state's pioneering role in developing new cures and solving health care challenges. We also appreciate Senator Bennet's leadership and the strong partnership he's built with the FDA."

Michael Bennet, U.S. Senator for Colorado says:
"Colorado is home to one of the fastest growing bioscience sectors, leading the way on life-changing research and development. Dr. Gottlieb's visit was an opportunity for researchers and innovators to engage with the FDA's leading voice in Washington. We look forward to continuing our work together to ensure lifesaving treatments make it to patients quickly and safely."

Don Elliman, Chancellor, University of Colorado Anschutz Medical Campus says:
"We're happy to host Senator Bennet and Commissioner Gottlieb at the University of Colorado Anschutz Medical Campus, where we are pioneering bioscience collaboration every day. The evolving health care landscape requires new models for innovation, and CU Anschutz is creating them. On our campus, the collaboration of the bioscience industry with our researchers and clinicians enables concepts to move from the research stage into practice, yielding breakthroughs in bioscience and real-world impacts on health care."

Participants in the roundtable represented the state's thriving life science sector, with more than 720 companies and institutions that support 159,000 bioscience-related jobs. CBSA members taking part in today's discussion highlighted diversity and innovation in CBSA's 350-strong member base.

The Anschutz Medical Campus and adjoining Fitzsimons Innovation Campus Bioscience Park Center are home to several of the state's leading life science companies, research hospitals and institutions. The Anschutz Campus is recognized as one of the nation's leading medical complexes.

About the Colorado BioScience Association

Colorado BioScience Association champions life science. We serve as the hub of Colorado's thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and mobile digital health companies, research and academic institutions and service providers. Learn more about us at http://www.cobioscience.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170822006213/en/